GlaxoSmithKline Consumer Healthcare; recalls

GlaxoSmithKline Consumer Healthcare; has 10 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 30 Apr 2014. The most frequent reason is potency & assay.

Total recalls10since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 30 Apr 2014

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 0 0%Class III 10 100%

Why glaxosmithkline consumer healthcare; is recalled

Product types

By year

All glaxosmithkline consumer healthcare; recalls, newest first

10 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIINicotine polacrilex lozenge, 4 mg, Cherry Flavor cartons recalledGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicotine polacrilex lozenge, 2 mg, Mint Flavor cartons recalledGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicotine polacrilex lozenge, 4 mg, Mint Flavor recalledGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicorette (nicotine polacrilex) Lozenges Mini, 2 mg recalledNicoretteGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicotine polacrilex lozenge, 4 mg, Original Flavor cartons recalledNicoretteGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicotine polacrilex lozenge, 2 mg, Cherry Flavor vials, and vials recalledGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicorette (nicotine polacrilex) Lozenges Mini, 4 mg recalledNicoretteGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicorette Lozenge, Nicoderm CQ recalled by GlaxoSmithKline ConsumerGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicotine polacrilex lozenge, 2 mg, Original Flavor cartons recalledNicoretteGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide
DrugCLASS IIINicorette Lozenge and NicoDerm CQ, nicotine polacrilex system recalledGlaxoSmithKline Consumer Healthcare;Potency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.